Ocugen Stock News

Select analysts and investment banks are looking for these fast-growing stocks to skyrocket in 2022.

Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock?

The biotech's prospects still look bright.

NEW YORK , Feb. 23, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for REVB, OCGN, VRT, KGC, and VIPS. Full story available on Benzinga.com

Ocugen Inc. (NASDAQ:OCGN) traded at $4.23 at close of the session on Tuesday, 02/22/22, made an upward move of 22.25% on its previous days price. Looking at the stock we see that its previous close was $3.46 and the beta (5Y monthly) reads 4.60 with the days price range being $3.72 $4.53. In terms What Does Ocugen Inc.s (NASDAQ: OCGN) Future Hold? Read More »

Ocugen Inc (NASDAQ: OCGN ) shares are trading Full story available on Benzinga.com

Revelation Biosciences REVB +29%. Mainz Biomed MYNZ +9%. Kodiak Sciences KOD -78%. Ocugen OCGN -20%.

Our call of the day from newsletter editor Jon Wolfenbarger says the evidence is piling up for a bear market. He's got ideas on how to profit.

Ocugen is down more than 20% after announcing a common stock offering. Could this possibly present a buying opportunity for OCGN stock?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips After rising sharply in recent days, Ocugen shares are again falling on news that the company is issuing $50 million of common stock. The post OCGN Stock Alert: The $50 Million Reason Ocugen Is Tanking Today appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. Get in Now on Tiny $3 Forever Battery Stock Interested in Crypto? Read This First

These stocks to sell run the gamut in terms of industry, but they all have one thing in common: the pros think they ought to be sold. The post 7 Popular Stocks That Pros Agree You Should Punt From You

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Kodiak's Wet AMD Treatment KSI-301 Did Not Meet Primary Endpoint In Phase 2b/3 Study Kodiak Sciences

Vertiv (VRT) stock isn't doing so hot on Wednesday following the release of the manufacturing company's earnings report for Q4 2021. The post Vertiv News: Why Is VRT Stock Plunging Today?

Ocugen (OCGN) is down 14.9% premarket Wednesday after the firm has priced its underwritten public offering of ~15,973,420M shares of its common stock for gross proceeds

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP ) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE: INDO ) shares surged 44.1% to close at $6.47 on Tuesday. Meritor, Inc. (NYSE: MTOR ) shares climbed 43.8% to settle at $35.47. Cummins Inc (NYSE: CMI ) agreed to acquire electric powertrain solutions provider Meritor for about $3.7 billion, including assumed debt and net of acquired cash. China Natural Resources, Inc. (NASDAQ: CHNR ) surged 27.4% to close at $0.7901. Paltalk, Inc. (NASDAQ: PALT ) rose 26.1% to close at $3.96. Ocugen, Inc. (NASDAQ: OCGN ) gained 22.3% to close at $4.23. The FDA has lifted its clinical hold on Ocugens investigational new drug application seeking approval to conduct testing of the COVID-19 vaccine Covaxin in the U.S. Arteris, Inc. (NASDAQ: AIP ) climbed 19% to close at $17.83. Arteris is expected release its financial results for the fourth quarter on Thursday, March 3, 2022. SeaChange International, Inc. (NYSE: SEAC ) rose 18.9% to settle at $1.26.